Loading…
Loading…
MORF (Morphic Holding, Inc.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
| SWTX | SpringWorks Therapeutics, Inc. | $46.99 | $3.5B |
| MOR | MorphoSys AG | $18.96 | $2.9B |
| KDNY | Chinook Therapeutics, Inc. | $40.39 | $2.7B |
| MYOV | Myovant Sciences Ltd. | $26.98 | $2.6B |
| PRVB | Provention Bio, Inc. | $24.98 | $2.4B |
| LBPH | Longboard Pharmaceuticals, Inc. | $59.98 | $2.3B |
| DICE | DICE Therapeutics, Inc. | $47.55 | $2.3B |
| CALT | Calliditas Therapeutics AB (publ) | $40.00 | $2.1B |
| BLU | BELLUS Health Inc. | $14.75 | $1.9B |
| FUSN | Fusion Pharmaceuticals Inc. | $21.55 | $1.8B |